Tempus AI shares jump amid Medicare revenue optimism
Tempus AI stock rose 15% on Thursday and has advanced 36% over five sessions, after investor focus on expected Medicare reimbursement revenue for two cancer screenings.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.